These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16820527)

  • 1. Pain with donepezil.
    Kuloor CB; Puranik A
    Age Ageing; 2006 Nov; 35(6):639-40. PubMed ID: 16820527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 4. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 9. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mania associated with donepezil.
    Benazzi F
    J Psychiatry Neurosci; 1999 Nov; 24(5):468-9. PubMed ID: 10586539
    [No Abstract]   [Full Text] [Related]  

  • 11. Torsades de Pointes with QT prolongation related to donepezil use.
    Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
    J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of adverse drug reactions with donepezil versus memantine: analysis of the French Pharmacovigilance Database.
    Babai S; Auriche P; Le-Louët H
    Therapie; 2010; 65(3):255-9. PubMed ID: 20699079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
    Liu HC; Lin SK; Sung SM
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
    [No Abstract]   [Full Text] [Related]  

  • 14. Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease.
    Igeta H; Suzuki Y; Motegi T; Sasaki A; Yokoyama Y; Someya T
    Gen Hosp Psychiatry; 2013; 35(6):680.e9-10. PubMed ID: 23731891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus erythematosus associated with donepezil: a case report.
    Manzo C; Putignano S
    Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary incontinence: an unrecognised adverse effect with donepezil.
    Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
    Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation syndrome following donepezil cessation.
    Singh S; Dudley C
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):282-4. PubMed ID: 12673601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of donepezil-related torsades de pointes.
    Kitt J; Irons R; Al-Obaidi M; Missouris C
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil-induced linear IgA disease.
    Hussain K; Hepburn NC; Scharrer K; Zdybsky J; Schofield J
    Clin Exp Dermatol; 2012 Jan; 37(1):72-3. PubMed ID: 21689148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.